Shares for the Cure: Simplify Introduces Health Care ETF Benefiting Susan G. Komen
The Simplify Health Care ETF (PINK) will donate all net profits from its management to
- First ETF dedicated to donating all net profits to a breast cancer organization.
- Managed by experienced hedge fund manager Michael Taylor.
- Expense ratio set at a competitive 0.50%.
- Support for a critical cause, potentially attracting socially conscious investors.
- The fund is newly launched with a limited operating history, carrying inherent risks.
- High volatility associated with healthcare and biotech sectors may affect fund performance.
The Simplify Health Care ETF, trading under the symbol PINK, will donate all net profits from managing the fund on an annual basis to
New ETF is actively managed by renowned hedge fund manager
PINK will be actively managed by renowned hedge fund investor
“We’re very grateful for this tangible commitment by the Simplify team to create a long-term source of support for the important work we’re doing to save lives and pursue an end to breast cancer,” said
“Breast cancer impacts one in eight women in the
“The healthcare and biotech sectors are in the midst of a period of incredible innovation, rising to meet not only the ongoing pandemic, but producing breakthrough research that could have significant implications in the fight against cancer,” added
PINK has an expense ratio of 0.50 percent and Simplify has committed to donating all net profits from management of the fund to
ABOUT SIMPLIFY ASSET MANAGEMENT INC
ABOUT
Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the
Susan G. Komen’s mission is to save lives by meeting the most critical needs in our communities and investing in breakthrough research to prevent and cure breast cancer.
Investors should carefully consider the investment objectives, risks, charges and expenses of Exchange Traded Funds (ETFs) before investing. To obtain an ETF's prospectus containing this and other important information, please call (855) 772-8488, or visit SimplifyETFs.com. Please read the prospectus carefully before you invest. An investment in the fund involves risk, including possible loss of principal. Past performance does not guarantee future results.
The fund is new and has a limited operating history.
The Fund focuses its investments in securities of biotechnology and the healthcare industry. Economic, legislative or regulatory developments may occur that significantly affect these industries and cause the Fund’s net asset value to fluctuate due to this concentration.
The biotechnology industry can be significantly affected by patent considerations, including the termination of patent protections for products, intense competition both domestically and internationally, rapid technological change and obsolescence, government regulation and expensive insurance costs due to the risk of product liability lawsuits.
In addition, the biotechnology industry is an emerging growth industry, and therefore biotechnology companies may be thinly capitalized have limited product lines, distribution channels, resources and more volatile than companies with greater capitalizations. Biotechnology companies must contend with high development costs, which may be exacerbated by the inability to raise prices to cover costs because of managed care pressure, government regulation or price controls. Companies in the pharmaceutical industry are heavily dependent on patent protection. The expiration of patents may adversely affect the profitability of the companies. Pharmaceutical companies are also subject to extensive litigation based liability and approval of the
The Fund’s focus on the healthcare sector may cause its value to fluctuate and be more susceptible to particular risks of the sector such as extensive government regulations, restrictions on government reimbursement for medical expenses, rising costs of medical products and services, pricing pressure, an increased emphasis on outpatient services, changes in the demand for medical products and services, a limited number of products, industry innovation, changes in technologies and other market developments.
Simplify ETFs are distributed by
View source version on businesswire.com: https://www.businesswire.com/news/home/20211008005077/en/
MEDIA:
(212) 473-4442
patrick@macmillancom.com
Source: Simplify Asset Management
FAQ
What is the Simplify Health Care ETF (PINK)?
Who manages the Simplify Health Care ETF (PINK)?
What is the expense ratio for the Simplify Health Care ETF (PINK)?
How does the Simplify Health Care ETF (PINK) support breast cancer research?